NATURES SUNSHINE PRODUCTS INC Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2026-06-30 was 11.08%, a 26.28% increase year-over-year.
- NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2026-03-31 was 12.43%, a 101.32% increase year-over-year.
- NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2025-12-31 was 12.70%, a 158.23% increase year-over-year.
- NATURES SUNSHINE PRODUCTS INC return tang equity for the quarter ending 2025-09-30 was 9.15%, a 17.45% decline year-over-year.
- NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2025 was 12.70%, a 158.23% increase from fiscal 2024.
- NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2024 was 4.92%, a 52.36% decline from fiscal 2023.
- NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2023 was 10.33%, a 2650.17% increase from fiscal 2022.
- NATURES SUNSHINE PRODUCTS INC return tang equity for fiscal 2022 was 0.38%, a 98.00% decline from fiscal 2021.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |